NV1020
- Generic Name
- NV1020
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
NV1020, a genetically engineered herpes simplex virus, is a novel anticancer therapeutic.
- Indication
Intended for the treatment of various forms of cancer.
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath